Re: Holding RVNC -- It's small comfort but the time will not be completely wasted, I assume the long-term open label safety trial for cervical dystonia (ASPEN-OLS) continues and is accruing data, so at some point, assuming that is auccessful, they will be able to file for approval for their first therapeutic.
News 
Market Data 
Discover 
AI
